Drug intelligence / Profile preview

Ailitong ointment

Development stage: Preclinical
Lead developer: Guangdong Provincial Administration of Traditional Chinese Medicine
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Ailitong ointment is an externally applied medication currently under investigation for the treatment of cancer pain. Its mechanism of action is being studied, with research focusing on its effects based on NGS gene polymorphism. It is associated with institutions involved in Traditional Chinese Medicine.

Other names: Ailitong癌理通膏

Beyond the preview

Go deeper on Ailitong ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ailitong ointment.

Explore the full profile